REAP Financial Group’s CONMED CNMD Stock Holding History

REAP Financial Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19	Closed	-$2.08K	–	604
2023 Q4	$2.08K	Buy	+19	New	+$1.97K	﹤0.01%	545

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

REAP Financial Group's CNMD Position: Q1 2024 in Review

REAP Financial Group sold out of CONMED (CNMD) in Q1 2024, closing a stake of 19 shares — an estimated $2.08K sold.

REAP Financial Group first reported a position in CNMD in Q4 2023 and held it in 1 quarter. The position peaked at $2.08K in Q4 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

REAP Financial Group reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
REAP Financial Group sold 19 CONMED shares in Q1 2024, an estimated $2.08K.
REAP Financial Group first reported a position in CONMED in Q4 2023 and held it in 1 quarter.
REAP Financial Group's CONMED position peaked at $2.08K in Q4 2023.
298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on REAP Financial Group's 13F filing for Q1 2024, filed 27 Feb 2025.